Eli Lilly (LLY) exec says that price is expected to drag on growth in the low to mid teens range in 2026

Eli Lilly's executive comments indicate that pricing pressures will likely constrain growth to the low to mid-teens through 2026.

Newsquawk StaffPublished On the live feed at 18 more headlines followed before this page went public
Newsquawk headlinesUTC

Newsquawk European Market Wrap - 4th February 2026

Barclays (BARC LN) and NatWest (NWG LN) to submit formal offer over GBP 2bln for wealth manager Evelyn, via Sky News

Eli Lilly (LLY) exec says that price is expected to drag on growth in the low to mid teens range in 2026

Eli Lilly's (LLY) CEO says that the number of people engaging with the Lilly direct has increased to over 1mln patients in 2025

Turkish President Erdogan says they oppose US military intervention against Iran

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This suggests potential challenges in maintaining margins, which could impact investor sentiment and the stock's performance in the near term. Watch for how this narrative might affect broader sector valuations and peers in the pharmaceuticals space.

Related headlines

The whole workspace, free to try.

Try it free